Company intelligence / Profile preview

Phoenix Molecular Imaging

Scottsdale / Phoenix area, Arizona, United Statesdnb.com ↗

Ownership: Private
Development stage: Commercial

Overview

Phoenix Molecular Imaging is an active medical diagnostics company specializing in advanced PET/CT molecular imaging, particularly for prostate cancer. The center is recognized for its leadership in the development of PET/CT techniques and offers state-of-the-art diagnostic services to patients in the greater Phoenix area.

Therapeutic areas: Oncology
Modalities: RadiopharmaceuticalDevice (PET/CT scanner)
Industry: Medical Imaging

Beyond the preview

Go deeper on Phoenix Molecular Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phoenix Molecular Imaging.

Explore the full profile